Today, a Call to Action was announced urging all those involved in the new EU Joint Clinical Assessment (JCA) to recognize and use all types of available clinical evidence, including single-arm trials and real-world evidence, in the assessment of Advanced Therapy Medicinal Products (ATMPs), which include cell and gene therapies. This Call to Action is […]